Cargando…
First person – Jianhao Zeng
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668024/ http://dx.doi.org/10.1242/dmm.050510 |
_version_ | 1785149073447190528 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer’, published in DMM. Jianhao conducted the research described in this article while a PhD student in Hui Zong's lab at University of Virginia Health System, Charlottesville, VA, USA. He is now a postdoc in the lab of Hamideh Parhiz at University of Pennsylvania, Philadelphia, PA, USA, investigating mRNA-based in vivo cellular reprogramming for cancer prevention and treatment. |
format | Online Article Text |
id | pubmed-10668024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-106680242023-11-13 First person – Jianhao Zeng Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Jianhao Zeng is first author on ‘ A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer’, published in DMM. Jianhao conducted the research described in this article while a PhD student in Hui Zong's lab at University of Virginia Health System, Charlottesville, VA, USA. He is now a postdoc in the lab of Hamideh Parhiz at University of Pennsylvania, Philadelphia, PA, USA, investigating mRNA-based in vivo cellular reprogramming for cancer prevention and treatment. The Company of Biologists Ltd 2023-11-13 /pmc/articles/PMC10668024/ http://dx.doi.org/10.1242/dmm.050510 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Jianhao Zeng |
title | First person – Jianhao Zeng |
title_full | First person – Jianhao Zeng |
title_fullStr | First person – Jianhao Zeng |
title_full_unstemmed | First person – Jianhao Zeng |
title_short | First person – Jianhao Zeng |
title_sort | first person – jianhao zeng |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668024/ http://dx.doi.org/10.1242/dmm.050510 |